These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 12153370)

  • 1. Representation of the elderly, women, and minorities in heart failure clinical trials.
    Heiat A; Gross CP; Krumholz HM
    Arch Intern Med; 2002 Aug 12-26; 162(15):1682-8. PubMed ID: 12153370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
    Kristensen SL; Køber L; Jhund PS; Solomon SD; Kjekshus J; McKelvie RS; Zile MR; Granger CB; Wikstrand J; Komajda M; Carson PE; Pfeffer MA; Swedberg K; Wedel H; Yusuf S; McMurray JJ
    Circulation; 2015 Jan; 131(1):43-53. PubMed ID: 25406306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of heart failure in older patients: results from the National Heart Failure project.
    Havranek EP; Masoudi FA; Westfall KA; Wolfe P; Ordin DL; Krumholz HM
    Am Heart J; 2002 Mar; 143(3):412-7. PubMed ID: 11868045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings.
    Patel HC; Hayward C; Dungu JN; Papadopoulou S; Saidmeerasah A; Ray R; Di Mario C; Shanmugam N; Cowie MR; Anderson LJ
    J Card Fail; 2017 Jul; 23(7):517-524. PubMed ID: 28434933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Representation of elderly persons and women in published randomized trials of acute coronary syndromes.
    Lee PY; Alexander KP; Hammill BG; Pasquali SK; Peterson ED
    JAMA; 2001 Aug; 286(6):708-13. PubMed ID: 11495621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Representation of black patients in randomized clinical trials of heart failure with reduced ejection fraction.
    Sullivan LT; Randolph T; Merrill P; Jackson LR; Egwim C; Starks MA; Thomas KL
    Am Heart J; 2018 Mar; 197():43-52. PubMed ID: 29447783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Ibrahim NE; Gaggin HK; Rabideau DJ; Gandhi PU; Mallick A; Januzzi JL
    J Card Fail; 2017 Feb; 23(2):121-130. PubMed ID: 27469482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The exclusion of the elderly and women from clinical trials in acute myocardial infarction.
    Gurwitz JH; Col NF; Avorn J
    JAMA; 1992 Sep; 268(11):1417-22. PubMed ID: 1512909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Fisher SA; Brunskill SJ; Doree C; Mathur A; Taggart DP; Martin-Rendon E
    Cochrane Database Syst Rev; 2014 Apr; (4):CD007888. PubMed ID: 24777540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials.
    Hernandez AV; Usmani A; Rajamanickam A; Moheet A
    Am J Cardiovasc Drugs; 2011; 11(2):115-28. PubMed ID: 21294599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender does not affect postdischarge outcomes in patients hospitalized for worsening heart failure with reduced ejection fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan [EVEREST] Trial).
    Shah AN; Mentz RJ; Gheorghiade M; Kwasny MJ; Fought AJ; Zannad F; Swedberg K; Maggioni AP; Konstam MA
    Am J Cardiol; 2012 Dec; 110(12):1803-8. PubMed ID: 22999071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.
    Shah KS; Xu H; Matsouaka RA; Bhatt DL; Heidenreich PA; Hernandez AF; Devore AD; Yancy CW; Fonarow GC
    J Am Coll Cardiol; 2017 Nov; 70(20):2476-2486. PubMed ID: 29141781
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.